newsfilter
← Latest News
ACCESS Newswire·

Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides

SHELTON, CONNECTICUT / ACCESS Newswire / February 10, 2026 / NanoViricides, Inc., a publicly traded company , and a clinical stage, leading global pioneer in the development of broad-spectrum